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Abstract
Background: The diffusion of cross-sectional imaging has recently permitted the detection of an increasing
number of incidentalomas localized in the distal pancreas.
Currently, there are no studies in the literature exploring the laparoscopic approach as treatment for left-sided
pancreatic incidentalomas.
Methods and results: We report a series of 20 incidentalomas localized in the body and tail of the pancreas
treated with laparoscopic surgery over the period 2010–2014. The incidental masses of our series included a great
variety of histotypes and a relevant proportion of malignant lesions. In two cases, the laparoscopic procedures were
converted to open surgery. No postoperative death was observed. The postoperative pancreatic fistula rate was
20 %, and the new-onset diabetes rate was 25 %.
Conclusions: Left-sided pancreatic incidentalomas in patients with minor comorbidities can be safely treated with
laparoscopic approach. Only clinical trials will confirm whether laparoscopic surgery is an effective treatment for
malignant lesions.
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Background
Pancreatic incidentalomas (PIs) are asymptomatic masses
accidentally diagnosed by radiological, endoscopic, or la-
boratory exams performed for symptoms not suggesting
pancreatic diseases [1]. Masses confined to the body and
tail of the gland are frequently asymptomatic, but recently,
an increasing number of these lesions has been detected,
due to the large use of cross-sectional imaging [2]. To date,
only few series of PIs have been reported in the literature,
and consequently, some aspects of their management are
still debated [3–7].
Laparoscopic distal pancreatectomy (LDP) is actually
considered an effective and safe treatment for benign
and premalignant left-sided pancreatic tumors [8–11].
Minimally invasive surgery could be a good choice for
the treatment of incidental masses of the distal pancreas,
but currently, there are no studies in the literature con-
firming this hypothesis.
We report a series of 20 incidentalomas localized in
the body and tail of the pancreas treated with laparo-
scopic approach.
Methods
After obtaining local ethics committee approval, we
retrospectively reviewed the medical records of all the
patients who underwent distal pancreatectomy at the
General Surgery Division of Alessandro Manzoni
Hospital, from January 2010 to December 2015. Our
institution is categorized as a medium-volume hospital
for pancreatic surgery [12]. Only patients with asymp-
tomatic incidentally identified lesions treated with
laparoscopic approach were included into the study. The
data collected were as follows: preoperative data—age,
gender, ethnicity, body mass index (BMI), American
Society of Anesthesiologists (ASA) physical status
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classification, indication and type of imaging exams, and
tumor size and location; intraoperative data—type of
resection and operative time; pathological diagnosis and
staging (according to the 7th edition of American Joint
Committee on Cancer TNM staging system); and post-
operative outcomes—perioperative mortality, length of
hospital stay, readmission, postoperative pancreatic fis-
tulas (POPF) [13], post-pancreatectomy diabetes (PPD)
[14], and generic complications.
LDP was performed according to the standard tech-
nique described in the literature [15]. The pancreas was
transected with a linear cutting stapler (Endopath® ETS
Linear Cutter—Ethicon Endo-Surgery Inc., Cincinnati
OH, USA); no extra suture was performed routinely. One
suction drain was left close to the transected pancreas.
In patients with malignant neoplasm, the radiological
follow-up consisted in CT scan every 6 months. Informed
consent for publishing personal data was obtained from
each patient included in the study.
Results
We retrospectively collected 34 cases of tumors of the dis-
tal pancreas that underwent surgery during the period
2010–2015: 22 patients (64.7 %) were asymptomatic and
20 (58.8 %) were treated with laparoscopic approach. The
mean age was 63.4 years (range 26–78). Fourteen patients
were female and 6 male. All patients were Caucasian. The
median BMI was 24.75—interquartile (IQ) range 23.7–
26.2. Four patients were classified ASA 1 (20 %), 12 pa-
tients ASA 2 (60 %), and 4 patients ASA 3 (20 %). The
main radiological, pathological, and surgical characteristics
of the series are summarized in Tables 1 and 2.
In 12 patients, diagnosis was made during diagnostic
work-up in the emergency department (ED). In three pa-
tients, the suspected diagnosis was pulmonary embolism;
in two, colonic diverticulitis; and in one, pericarditis. In
three patients presenting with hematuria and three with
renal stones, PI was an incidental finding.
In six cases, imaging was performed for follow-up
(two for pelvic cyst, two for uterine carcinoma, and one
for prostate carcinoma) or for staging (one for oral neo-
plasm). In two patients, PI was detected due to an in-
crease of serum amylases.
Radiological diagnosis was made by abdominal ultrason-
ography (US) in 5 patients and computed tomography
(CT) scan in 15 patients. In nine cases, CT was performed
in ED.
In two cases, the laparoscopic procedures were con-
verted to open surgery for the large size of PI. The median
operative time was 203.5 min (IQ range 193–218.5). The
median postoperative hospital stay was 7.5 days (IQ range
6–10). Four patients (20 %) developed POPF: 2 were grade
A and 2 grade B fistulas. No emergent reintervention was
required and conservative management was adopted in all
cases. Two patients with grade B fistulas were treated with
enteral nutrition and antibiotic therapy; the drainage was
maintained in place until leakage resolution. In one case,
the patient was discharged with drain in situ and reevalu-
ated in an outpatient setting. In our series, the median
persistency of POPF was 16 days. In 4 cases (20 %), post-
operative pleural effusion was observed: in 2 patients, it
was associated with grade B pancreatic fistulas, and in 2
cases, it was secondary to pneumonia; one patient re-
quired thoracentesis. Five patients (25 %) developed PPD
during the postoperative course. In our series, no case of
postoperative death or readmission was observed at 90-
day follow-up.
In 8 patients (40 %), the PI was located in the body of
the gland; in 9 patients (45 %), in the tail; and in 3 patients
(15 %), between the body and tail.
In all the patients, the resection margins were nega-
tive for tumor involvement. Histology revealed ductal
adenocarcinoma (DAC) in six patients—associated with
undifferentiated carcinoma and intraductal papillary
mucinous neoplasm (IPMN) in two patients; neuroen-
docrine tumor in five patients (two presented the cystic
variant); and two cases of acinar cell carcinoma (ACC).
Serous cystic neoplasm was detected in two patients,
mucinous cystic neoplasm in two patients, solid pseu-
dopapillary neoplasm in two patients, and one patient
showed an isolated IPMN.
The mean follow-up of the cohort was 31 months. All
the patients with cystic neoplasms or neuroendocrine tu-
mors were alive without disease recurrence in December
2015. In 8 patients with DAC and ACC, the median num-
ber of lymph nodes removed was 15 (IQ range 13.5–17).
In this specific sub-group, pathological staging was stage I
B in one patient, stage II A in four patients, and stage II B
in three patients. The median follow-up time of this sub-
group was 17 months: six of eight patients died of tumor
recurrence, while two patients are alive in December 2015
(one with disease recurrence).
Discussion
The preoperative work-up of a pancreatic lesion should
determine its nature in order to plan the most accurate
treatment. Nevertheless, in some cases PIs are not easy
to characterize preoperatively [2]. Incidental masses of
the pancreas include a great variety of lesions and
unusual histotypes are frequently counted in the series
present in the literature [4, 5, 7]. Differently from DAC,
uncommon histological types with a lower biological
aggressiveness, such as mucinous cystic neoplasms or
neuroendocrine tumors, are preferentially located in the
distal pancreas [16–18]: in our series, we found two
ACC, two cystic neuroendocrine tumors, and two solid
pseudopapillary neoplasms (Figs. 1, 2, and 3). Further-
more, in about 7 % of patients with a pancreatic mass is
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not possible to establish a definitive diagnosis before sur-
gery despite a complete preoperative imaging [19].
The diagnostic work-up of our series was character-
ized by the exiguity of preoperative exams. Solid masses
localized in the distal pancreas are very frequently
suitable for surgical resection, and consequently, CT
findings are sufficient to plan the more appropriate man-
agement of a left-sided incidentaloma in the majority of
the cases [7, 20].
All patients underwent a contrast-enhanced multide-
tector CT scan with a biphasic protocol (arterial and
venous phases). Currently, intravenous contrast-
enhanced CT scan is considered the pivotal radiological
technique for the detection, definition, and staging of
pancreatic masses [21–23]. In the last decade, the use
of CT imaging increased by threefold in emergency-
treated patients [24]: in our series, eight cases of PI
were discovered by a CT scan performed in patients
evaluated in the ED.
A relevant proportion of PIs were detected by transab-
dominal US. US is considered the first-level imaging in
hepato-biliary disease, but the deep location of the pan-
creas and the operator dependency make the US an
exam with low accuracy for the correct assessment of a
pancreatic tumor [21].
Magnetic resonance imaging (MRI) and endoscopic
ultrasound (EUS) were performed in selected cases. A
complete pancreatic MRI study including pre- and
post-gadolinium T1-weighted sequences, T2-weighted
sequences, and magnetic resonance cholangiopancrea-
tography was performed for the definition of the local
extension of poorly defined solid masses and the dif-
ferentiation of cystic neoplasms [22, 23, 25].
EUS with fine-needle aspiration (FNA) provides high-
resolution images and relevant information about
cytology and tumor markers of solid and cystic lesions,
but the high operator dependency is the limit of the
exam [21, 22]. EUS presents a high accuracy for small
solid tumors, and EUS-FNA may be useful in the differ-
ential diagnosis of pancreatic cystic masses [25–27].
Over recent years, we have employed EUS more fre-
quently in the diagnostic work-up of PIs.
Surgical resection is considered the standard treatment
for asymptomatic pancreatic solid neoplasms [1, 6].
Conversely, the management of cystic PIs is generally
conservative due to the benign nature of the majority of
Table 1 Demographic, radiological, and pathological data of 20 cases of left-sided pancreatic incidentalomas treated with laparoscopic
approach
No. Age Sex BMI ASA score Imaging Location Size (cm) Histology
1 69 F 21.4 2 CT-MRI Body 4.5 SCN
2 39 F 22.9 1 US-CT Body-tail 9.0 SPPN
3 62 M 25.7 1 CT Tail 1.5 NET
4 65 M 23.7 2 CT-MRI Body 3.5 IPMN
5 55 F 23.9 2 CT-MRI Body-tail 4.5 MCN
6 75 F 26.1 3 CT Tail 3.8 ACC
7 72 M 32.6 2 CT Body 5.4 DAC + UC
8 72 F 23.7 2 US-CT Body 4.5 DAC
9 71 F 25.8 2 CT-EUS Body 3.7 ACC
10 61 F 24.8 2 CT-MRI Tail 3.5 SCN
11 26 F 24.2 1 US-CT-MRI Tail 9.5 SPPN
12 72 F 31.4 3 CT-MRI Tail 2.4 IPMN + DAC
13 76 F 24.7 2 CT-EUS Body 1.6 DAC
14 49 F 22.3 1 CT-EUS Tail 2.5 NET
15 78 F 27.3 3 US-CT-MRI Body-tail 6.2 MCN
16 52 M 27.8 2 CT Tail 5.3 CNET
17 75 M 24.7 3 CT-EUS Body 2.5 DAC
18 67 F 26.3 2 US-CT Tail 1.8 NET
19 65 M 24.8 2 CT-EUS Tail 3.0 DAC
20 67 F 21.5 2 CT-MRI Body 4.5 CNET
BMI body mass index, ASA American Society of Anesthesiologists, US ultrasonography, CT computed tomography, MRI magnetic resonance imaging, EUS
endoscopic ultrasound, SCN serous cystic neoplasm, MCN mucinous cystic neoplasm, SPPN solid pseudopapillary neoplasm, IPMN intraductal papillary mucinous
neoplasm, NET neuroendocrine tumor, CNET cystic neuroendocrine tumor, ACC acinar cell carcinoma, DAC ductal adenocarcinoma, UC undifferentiated carcinoma LDP
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these lesions [2]. Serous cystic neoplasm (SNC) is consid-
ered a benign lesion, and surgery should be considered
only in case of large tumors (size >4 cm) or when pre-
operative exams are not conclusive [28]. Mucinous cystic
neoplasms (MCN) and IPMN are frequently incidental
[25]. Surgical resection is mandatory for MCN and main
duct-type IPMN [29]. Branch duct-type IPMN should be
considered for surgery only in case of a lesion greater than
3 cm associated with main duct dilatation >10 mm or an
enhanced solid component [29].
A relevant proportion of PIs are malignant or prema-
lignant lesions [6, 7]. Malignancies detected inciden-
tally are diagnosed in earlier stages, and long-term
survivals seem to be more favorable than symptomatic
lesions [7]. In our series, in six cases the histologic
diagnosis of left-sided PI was DAC, and in two
patients, it was ACC. Despite a complete preoperative
diagnostic work-up, the final pathological staging dem-
onstrated a relevant proportion of tumors with infiltra-
tion of surrounding tissues or microscopic lymph node
involvement: four patients were classified as stage II A
and three patients as stage II B. Consequently, when a
pancreatic mass is detected, surgical treatment should
be always considered [20].
The distal pancreatectomy consists in the resection of
body and tail of the pancreas including the spleen and
regional lymph nodes: it is considered the standard
treatment of left-sided malignancies. Minimally inva-
sive surgery was introduced for DAC staging, and sub-
sequently, it was employed for pancreatic resections
[8, 15]. LDP is currently considered an effective treat-
ment for benign and low-grade malignant lesions of
the distal pancreas, but it is still debating if this tech-
nique is an appropriate treatment for DAC [8–11]. In
the series presented in the literature, LDP was per-
formed for non-malignant lesions in the majority of
cases, but there are not clinical trials comparing long-
term survivals of patients with DAC treated with lap-
aroscopic or open approach [11]. In the meta-analysis
of the literature, the tumor free margin rate and num-
ber of lymph nodes dissected are comparable in both
techniques, but no definitive conclusions can be
drawn about outcomes of laparoscopic resection for
malignancy [9, 10]. However, LDP presents lower
blood loss, shorter time to oral intake, and reduced
length of hospital stay as compared to open surgery,
while the rate of postoperative pancreatic fistulas is
similar for the two surgical techniques [8–10].
We consider the presence of lymph node involve-
ment and infiltration of surrounding tissues at pre-
operative work-up as contraindications to laparoscopic
approach. In our series, conversion to open surgery
Table 2 Surgical and follow-up data of 20 cases of left-sided pancreatic incidentalomas treated with laparoscopic approach
No. Surgery Operative time (min) Postop stay Complications Follow-up
1 LDP 204 7 – AD
2 LDP 215 10 P, PE AD
3 LSPDP 228 5 – AD
4 LDP 220 12 POPF AD
5 LDP 217 10 P, PE AD
6 LDP 210 5 – D
7 LDP-CO 235 8 PPD D
8 LDP 191 11 POPF, PE D
9 LDP 188 9 PPD D
10 LDPDP 198 5 – AD
11 LDP 162 6 – AD
12 LDP 238 8 PPD PD
13 LDP 172 14 POPF D
14 LDPDP 197 5 – AD
15 LDP-CO 212 7 PPD AD
16 LDPDP 230 6 – AD
17 LDP 203 22 POPF, PE D
18 LDP 185 6 – AD
19 LDP 195 7 – AD
20 LDP 200 9 PPD AD
LDP laparoscopic distal pancreatectomy, LSPDP laparoscopic spleen-preserving distal pancreatectomy, CO, converted to open, PE pleural effusion, POPF postoperative
pancreatic fistula, P pneumonia, PPD post-pancreatectomy diabetes, AD absence of disease, PD progression of disease, D died
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was determined by the intraoperative detection of
considerable-size masses causing the failure to progress.
Laparoscopic spleen-preserving distal pancreatectomy was
performed in two patients for small benign lesions local-
ized in the tail. In patients with diagnosis of DAC, the
number of lymph nodes removed was adequate for a cor-
rect oncologic resection.
The absence of postoperative deaths could be related
to the epidemiologic features of our cohort: the series
was composed by relatively young patients without con-
siderable comorbidities.
In our series, the postoperative fistula rate was slightly
high, but it was still in the range reported in the litera-
ture [10, 30]. No grade C fistula was observed, and in
two cases, the pancreatic leak was only biochemical
without any clinical relevance. Our high POPF rate may
be attributed to lack of oversewing of the pancreatic
stump, but any conclusions about the correlation
Fig. 2 Case 2. a Surgical specimen of distal pancreatectomy containing a 9.5-cm-large encapsulated pancreatic tail mass with areas of cystic
degeneration. The histological diagnosis was solid pseudopapillary neoplasm. b The microscopic pattern of the neoplasm is solid and pseudopapillary with
poorly cohesive monomorphic cells, admixed with thin-walled blood vessels. At the center of the image, there are characteristic cholesterol
crystals, surrounded by foreign-body giant cells (hematoxylin-eosin; magnification ×200)
Fig. 1 Case 16. a CT scan demonstrating a 3 × 4 cm pancreatic tail cystic lesion. b Surgical specimen of spleen-preserving distal pancreatectomy
with a cystic lesion of the tail. A well-demarcated, solitary, and cystic mass of the pancreatic tail is a rare macroscopic presentation of a neuroendocrine
tumor. c The characteristic trabecular and gyriform pattern of a pancreatic neuroendocrine tumor with relatively uniform cells (hematoxylin-eosin;
magnification ×40). d The immunohistochemical staining shows strong and diffuse expression of chromogranin A (magnification ×200)
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between the type of surgical closure of the remnant
gland and POPF cannot be drawn due to the limited
number of the series.
Pleural effusion, a rare complication [8], was observed in
four patients. In two cases, pleural effusion was associated
with grade B pancreatic fistulas; in two cases was secondary
to pneumonia, and it was self-limiting. Pleural and pulmon-
ary complications are considered infrequent complications
in pancreatic surgery, but a large observational study shows
how LDP is associated with a pleuro-pulmonary morbidity
rate of 26 % [11].
The incidence of PPD was consistent with the data of
the literature [31].
Conclusions
In conclusion, circumscribed incidentalomas of the distal
pancreas in patients with minor comorbidities could be
safely treated with laparoscopic approach. Left-sided PIs
are frequently uncommon pancreatic neoplasms, but in a
significant share of patients, DAC in early stages are
found. In case of large-sized tumors or lymph node
involvement, open surgery should be considered. Only
clinical trials will confirm whether laparoscopic surgery is
an effective treatment for malignant lesions [11].
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